← Leaderboards
Wendy M Leisenring
Fred Hutchinson Cancer Research Center
$3,394,032
Attributed
$3,394,032
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $658.1K · FY2013–24$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,394,032 · 2
By mechanism
R01$2,592,255 · 1
U24$801,777 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Philip D Greenberg$5,134,650
- Claudio Anasetti$8,370,314
- Aude Chapuis$3,514,981
- Shelly Heimfeld$10,960,565
- Jennifer M Lund$18,457,976
Others in their field
Top investigators on “Monitor”
- Jeffrey P Krischer · University Of South Florida$631,818,376
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$476,087,269
- Bambra Strokes · Ppd Development Lp$461,655,950
- David Heimbrook · Leidos Biomedical Research, Inc.$367,240,481
- Lawrence Corey · Fred Hutchinson Cancer Center$302,301,802
Research focus
MonitorTrendIncidenceProtocols DocumentationAdultSurvivorsPatient CareBaseDoseAdolescenceCongenital AbnormalityCancer PatientChemotherapyConduct Clinical TrialsDoxorubicinCostBiologicalConstitutionalCyclophosphamideAbdomenCohortBirth RateBirth WeightChildhood
Grant awards (8)
2/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis$234,888
U24 · FY2024 · HL · contact PI
2/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis$330,588
U24 · FY2023 · HL · contact PI
2/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis$236,301
U24 · FY2022 · HL · contact PI
Late Effects of Treatment in Wilms Tumor Survivors and Offspring$44,259
R01 · FY2017 · CA · contact PI
Late Effects of Treatment in Wilms Tumor Survivors and Offspring$636,039
R01 · FY2016 · CA · contact PI
Late Effects of Treatment in Wilms Tumor Survivors and Offspring$616,064
R01 · FY2015 · CA · contact PI
Late Effects of Treatment in Wilms Tumor Survivors and Offspring$658,124
R01 · FY2014 · CA · contact PI
Late Effects of Treatment in Wilms Tumor Survivors and Offspring$637,769
R01 · FY2013 · CA · contact PI